Clinical Trial

A Study of KC1086 in Patients With Advanced Solid Tumors

Name: A Study of KC1086 in Patients With Advanced Solid Tumors — clinical trial record (NCT07118709)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety，tolerability, pharmacokinetics, and preliminary efficacy of KC1086 in participants with advanced recurrent or metastatic solid tumors. The trial will be divided into two parts: dose-escalation phase and dose-expansion phase.

Trial Details

NCT Number	NCT07118709
Lead Sponsor	Beijing Konruns Pharmaceutical Co., Ltd.
Conditions	Advanced Solid Tumors Cancer
Enrollment	66 participants
Start Date	2025-08
Primary Completion	2028-08 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2025-08-12